Acurx Pharmaceuticals
ACXP
ACXP
14 hedge funds and large institutions have $5.27M invested in Acurx Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Holders
14
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$11.9K | |
| 2 | +$4.13K | |
| 3 | +$398 | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$40 |
Top Sellers
| 1 | -$740K | |
| 2 | -$72.9K | |
| 3 | -$48K | |
| 4 |
TWC
TD Waterhouse Canada
Toronto,
Ontario, Canada
|
-$47.1K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$5.33K |